UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of psoriasis as a systemic disease: what is the evidence?

British journal of dermatology (1951), 2020-04, Vol.182 (4), p.840-848

Korman, N.J.

2020

Volltextzugriff (PDF)

Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA

Clinical and experimental dermatology, 2016-07, Vol.41 (5), p.514-521

2016

Volltextzugriff (PDF)

Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3)

British journal of dermatology (1951), 2018-03, Vol.178 (3), p.674-681

2018

Volltextzugriff (PDF)

Comparative Effectiveness of Integrated Peer Support and Clinical Staffing Models for Community-Based Residential Mental Health Rehabilitation: A Prospective Observational Study

Community mental health journal, 2023-04, Vol.59 (3), p.459-470

2023

Volltextzugriff (PDF)

Tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: long‐term safety and efficacy in an open‐label extension study

British journal of dermatology (1951), 2018-10, Vol.179 (4), p.853-862

2018

Volltextzugriff (PDF)

Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up

British journal of dermatology (1951), 2015-05, Vol.172 (5), p.1371-1383

2015

Volltextzugriff (PDF)

Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity

Dermatology online journal, 2015-10, Vol.21 (10)

2015

Volltextzugriff (PDF)

Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials

The Journal of dermatological treatment, 2022-01, Vol.33 (1), p.219-228

2022

Volltextzugriff (PDF)

Protective Effects of Silymarin Against Photocarcinogenesis in a Mouse Skin Model

JNCI : Journal of the National Cancer Institute, 1997-04, Vol.89 (8), p.556-565

1997

Volltextzugriff (PDF)

Visualization of atherosclerosis as detected by coronary artery calcium and carotid intima-media thickness reveals significant atherosclerosis in a cross-sectional study of psoriasis patients in a tertiary care center

Journal of translational medicine, 2016-07, Vol.14 (1), p.217-217, Article 217

2016

Volltextzugriff (PDF)

Treatment outcomes with ixekizumab in patients with moderate‐to‐severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies

Journal of the European Academy of Dermatology and Venereology, 2017-04, Vol.31 (4), p.679-685

2017

Volltextzugriff (PDF)

Biopsychology of Physical Activity in People with Schizophrenia: An Integrative Perspective on Barriers and Intervention Strategies

Neuropsychiatric disease and treatment, 2022-01, Vol.18, p.2917-2926

2022

Volltextzugriff (PDF)

Community-care unit model of residential mental health rehabilitation services in Queensland, Australia: predicting outcomes of consumers 1-year post discharge

Epidemiology and psychiatric sciences, 2020-01, Vol.29, p.e109-e109, Article e109

2020

Volltextzugriff (PDF)

An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia

Schizophrenia research, 2019-04, Vol.206, p.450-451

2019

Volltextzugriff (PDF)

Patient satisfaction with current psoriasis treatment: a real-world study in the USA

Dermatology online journal, 2016-02, Vol.22 (2)

2016

Volltextzugriff (PDF)

136 Protective effects of apremilast against cardiovascular disease in psoriasis and the role of monocytes

Journal of investigative dermatology, 2024-08, Vol.144 (8), p.S24-S24

2024

Volltextzugriff (PDF)

Cicatricial pemphigoid

Journal of the American Academy of Dermatology, 2000-10, Vol.43 (4), p.571-594

2000

Volltextzugriff (PDF)

Ixékizumab : efficacité chez des patients atteints de psoriasis avec ou sans traitement biologique préalable ; résultats d’UNCOVER-1 semaines 12 et 60

Annales de dermatologie et de vénéréologie, 2016-12, Vol.143 (12), p.S397-S398

2016

Volltextzugriff (PDF)

Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions

Dermatology online journal, 2016-07, Vol.22 (7)

2016

Volltextzugriff (PDF)

Ixekizumab chez des patients atteints de psoriasis préalablement traités ou non par des biologiques : analyse intégrée de 2 études de phase 3

Annales de dermatologie et de vénéréologie, 2016-12, Vol.143 (12), p.S190-S190

2016

Volltextzugriff (PDF)

Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial

British journal of dermatology (1951), 2005-06, Vol.152 (6), p.1296-1303

2005

Volltextzugriff (PDF)

Impact of psoriasis flare and remission on quality of life and work productivity: a real-world study in the USA

Dermatology online journal, 2016-07, Vol.22 (7)

2016

Volltextzugriff (PDF)

Paraneoplastic Pemphigus: An Autoimmune Mucocutaneous Disease Associated with Neoplasia

The New England journal of medicine, 1990-12, Vol.323 (25), p.1729-1735

1990

Volltextzugriff (PDF)

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

Annals of the rheumatic diseases, 2014-06, Vol.73 (6), p.990-999

2014

Volltextzugriff (PDF)

Characterization of Paraneoplastic Pemphigus Autoantigens by Immunoblot Analysis

Journal of investigative dermatology, 1995-05, Vol.104 (5), p.829-834

1995

Volltextzugriff (PDF)

1 – 25 von 539

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(405)
Mit Volltextzugriff
(380)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Management of psoriasis as a systemic disease: what is the evidence?

Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA

Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3)

Comparative Effectiveness of Integrated Peer Support and Clinical Staffing Models for Community-Based Residential Mental Health Rehabilitation: A Prospective Observational Study

Tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: long‐term safety and efficacy in an open‐label extension study

Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up

Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity

Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials

Protective Effects of Silymarin Against Photocarcinogenesis in a Mouse Skin Model

Visualization of atherosclerosis as detected by coronary artery calcium and carotid intima-media thickness reveals significant atherosclerosis in a cross-sectional study of psoriasis patients in a tertiary care center

Treatment outcomes with ixekizumab in patients with moderate‐to‐severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies

Biopsychology of Physical Activity in People with Schizophrenia: An Integrative Perspective on Barriers and Intervention Strategies

Community-care unit model of residential mental health rehabilitation services in Queensland, Australia: predicting outcomes of consumers 1-year post discharge

An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia

Patient satisfaction with current psoriasis treatment: a real-world study in the USA

136 Protective effects of apremilast against cardiovascular disease in psoriasis and the role of monocytes

Cicatricial pemphigoid

Ixékizumab : efficacité chez des patients atteints de psoriasis avec ou sans traitement biologique préalable ; résultats d’UNCOVER-1 semaines 12 et 60

Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions

Ixekizumab chez des patients atteints de psoriasis préalablement traités ou non par des biologiques : analyse intégrée de 2 études de phase 3

Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial

Impact of psoriasis flare and remission on quality of life and work productivity: a real-world study in the USA

Paraneoplastic Pemphigus: An Autoimmune Mucocutaneous Disease Associated with Neoplasia

Characterization of Paraneoplastic Pemphigus Autoantigens by Immunoblot Analysis

Suchergebnisse filtern